ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Project 2 - Cell of origin contributions and vulnerabilities in clonal hematopoiesis

Active
Institution
Massachusetts General Hospital, MA
Principal investigator
David T Scadden
Funding
$488K
Duration
2017–2028
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary Heterogeneity within the hematopoietic stem cell (HSC) compartment is well defined and we hypothesize may contribute to the wide range of phenotypes emerging from initiation of clonal hematopoiesis (CH). This project will use distinctive tools for assessing cell state in the context of Tet2 deletion to determine how the epigenetic and transcriptional program of the cell of origin affects clonal dominance. These data will provide insight into the mechanisms of clonal dominance and may offer epigenetic signatures indicative of risk for subsequent validation. We will also focus on the metabolic state of dominant CH to define whether features of those cells render them vulnerable to low intensity intervention. Successful accomplishment will guide strategies for selective depletion of aberrant dominant clones.

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTEP01Heart, Lung, and Blood Program Project Study Section[HLBP]clonalhematopoiesisdominantoriginmetabolic statedominanceepigenetic transcriptionalclonal hematopoiesis

Questions for Massachusetts General Hospital

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.